RET and brain neoplasm: In aphenotype-based screen, 6-chloro-3-(2,4-dichloro-5-methoxyphenyl)-2-mecapto-7-methoxyquinazolin-4(3H) (CPT) was identified as a novel inhibitor of a Notch-induced brain tumor that acts on RET [89].